114 related articles for article (PubMed ID: 28323660)
1. Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
Calandra S; Tarugi P; Bertolini S
Curr Opin Lipidol; 2017 Jun; 28(3):267-272. PubMed ID: 28323660
[TBL] [Abstract][Full Text] [Related]
2. Additive Effect of
Marmontel O; Abou-Khalil Y; Bluteau O; Cariou B; Carreau V; Charrière S; Divry E; Gallo A; Moulin P; Paillard F; Peretti N; Rabès JP; Varret M; Carrié A; Di Filippo M
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):e270-e278. PubMed ID: 37128917
[TBL] [Abstract][Full Text] [Related]
3. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R; Bozon D; Belabbas K; MBou F; Girardet JP; Tounian P; Jolly M; Boccara F; Cohen A; Karsenty A; Dubern B; Carel JC; Azar-Kolakez A; Feillet F; Labarthe F; Gorsky AM; Horovitz A; Tamarindi C; Kieffer P; Lienhardt A; Lascols O; Di Filippo M; Dufernez F
J Lipid Res; 2016 Mar; 57(3):482-91. PubMed ID: 26802169
[TBL] [Abstract][Full Text] [Related]
4. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
6. Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease.
Sjouke B; Defesche JC; Hartgers ML; Wiegman A; Roeters van Lennep JE; Kastelein JJ; Hovingh GK
J Clin Lipidol; 2016; 10(6):1462-1469. PubMed ID: 27919364
[TBL] [Abstract][Full Text] [Related]
7. APOE p.Leu167del mutation in familial hypercholesterolemia.
Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
[TBL] [Abstract][Full Text] [Related]
8. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.
Bertolini S; Calandra S; Arca M; Averna M; Catapano AL; Tarugi P;
Atherosclerosis; 2020 Nov; 312():72-78. PubMed ID: 32977124
[TBL] [Abstract][Full Text] [Related]
9. The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes.
Cenarro A; Etxebarria A; de Castro-Orós I; Stef M; Bea AM; Palacios L; Mateo-Gallego R; Benito-Vicente A; Ostolaza H; Tejedor T; Martín C; Civeira F
J Clin Endocrinol Metab; 2016 May; 101(5):2113-21. PubMed ID: 27014949
[TBL] [Abstract][Full Text] [Related]
10.
Abou Khalil Y; Marmontel O; Ferrières J; Paillard F; Yelnik C; Carreau V; Charrière S; Bruckert E; Gallo A; Giral P; Philippi A; Bluteau O; Boileau C; Abifadel M; Di-Filippo M; Carrié A; Rabès JP; Varret M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628605
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia.
Abifadel M; Guerin M; Benjannet S; Rabès JP; Le Goff W; Julia Z; Hamelin J; Carreau V; Varret M; Bruckert E; Tosolini L; Meilhac O; Couvert P; Bonnefont-Rousselot D; Chapman J; Carrié A; Michel JB; Prat A; Seidah NG; Boileau C
Atherosclerosis; 2012 Aug; 223(2):394-400. PubMed ID: 22683120
[TBL] [Abstract][Full Text] [Related]
12. New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.
Elbitar S; Susan-Resiga D; Ghaleb Y; El Khoury P; Peloso G; Stitziel N; Rabès JP; Carreau V; Hamelin J; Ben-Djoudi-Ouadda A; Bruckert E; Boileau C; Seidah NG; Varret M; Abifadel M
Sci Rep; 2018 Jan; 8(1):1943. PubMed ID: 29386597
[TBL] [Abstract][Full Text] [Related]
13. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.
Baila-Rueda L; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Mateo-Gallego R; Lamiquiz-Moneo I; de Castro-Orós I; Cenarro A; Civeira F
Atherosclerosis; 2016 Mar; 246():202-7. PubMed ID: 26802983
[TBL] [Abstract][Full Text] [Related]
14. LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population.
Yang KC; Su YN; Shew JY; Yang KY; Tseng WK; Wu CC; Lee YT
J Formos Med Assoc; 2007 Oct; 106(10):799-807. PubMed ID: 17964958
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.
Huijgen R; Sjouke B; Vis K; de Randamie JS; Defesche JC; Kastelein JJ; Hovingh GK; Fouchier SW
Hum Mutat; 2012 Feb; 33(2):448-55. PubMed ID: 22095935
[TBL] [Abstract][Full Text] [Related]
16. Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia.
Di Taranto MD; Benito-Vicente A; Giacobbe C; Uribe KB; Rubba P; Etxebarria A; Guardamagna O; Gentile M; Martín C; Fortunato G
Sci Rep; 2017 Nov; 7(1):15282. PubMed ID: 29127338
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.
van der Graaf A; Avis HJ; Kusters DM; Vissers MN; Hutten BA; Defesche JC; Huijgen R; Fouchier SW; Wijburg FA; Kastelein JJ; Wiegman A
Circulation; 2011 Mar; 123(11):1167-73. PubMed ID: 21382890
[TBL] [Abstract][Full Text] [Related]
18. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia.
Motazacker MM; Pirruccello J; Huijgen R; Do R; Gabriel S; Peter J; Kuivenhoven JA; Defesche JC; Kastelein JJ; Hovingh GK; Zelcer N; Kathiresan S; Fouchier SW
Eur Heart J; 2012 Jun; 33(11):1360-6. PubMed ID: 22408029
[TBL] [Abstract][Full Text] [Related]
19. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia.
de Araújo JNG; de Oliveira VF; Borges JB; Dagli-Hernandez C; Marçal EDSR; Freitas RCC; Bastos GM; Gonçalves RM; Faludi AA; Jannes CE; Pereira ADC; Hirata RDC; Hirata MH; Luchessi AD; Silbiger VN
Gene; 2023 Jan; 849():146908. PubMed ID: 36167182
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020.
Leren TP; Bogsrud MP
Atherosclerosis; 2021 Apr; 322():61-66. PubMed ID: 33740630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
